1-5 of 5
Mark Hess
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

R-FND Followed by Radioimmunotherapy for High-Risk Follicular Lymphoma

Peter McLaughlin, MD, Sattva Neelapu, MD, Michelle Fanale, MD, Maria Rodriguez, MD, Ana Ayala, RN, Barbara Pro, M.D., F.B. Hagemeister, Anas Younes, Susan Neel, Nathan Fowler, Mark Hess, Larry W. Kwak
Journal: Blood
Blood (2008) 112 (11): 3056.
https://doi.org/10.1182/blood.V112.11.3056.3056
Published: 2008
Journal Articles

The Addition of Rituximab to CHOP Chemotherapy Improves Response Rate, Failure-Free Survival and Overall Survival for Follicular Grade 3 Lymphoma Compared to CHOP Alone

Michael J. Overman, MD, Lei Feng, MS, Barbara Pro, MD, Peter McLaughlin, MD, Mark Hess, BBA, Felipe Samaniego, MD, Anas Younes, MD, Jorge E. Romaguera, MD, Frederick B. Hagemeister, MD, Larry Kwak, MD, PhD, Fernando Cabanillas, MD, Maria A. Rodriguez, MD, Luis E. Fayad, MD
Journal: Blood
Blood (2007) 110 (11): 1289.
https://doi.org/10.1182/blood.V110.11.1289.1289
Published: 2007
Journal Articles

Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Analysis of 2083 Patients.

Apostolia-Maria Tsimberidou, MD, PhD, Susan O’Brien, M.D., Peter McLaughlin, M.D., Sijin Wen, M.S., William Wierda, M.D., Ph.D., Hagop M. Kantarjian, M.D., John Manning, M.D., Susan Lerner, M.S., Mark Hess, B.B.A., Emil J. Freireich, M.D., Michael J. Keating, M.D.
Journal: Blood
Blood (2006) 108 (11): 2790.
https://doi.org/10.1182/blood.V108.11.2790.2790
Published: 2006
Journal Articles

Time to Treatment Failure (TTF) and FLIPI Correlate Well with Survival and Are Independent Variables in Stage IV Indolent Follicular Lymphomas (IFL).

Luis Fayad, MD, Barbara Pro, MD, Qi Liu, MD, PhD, Mark Hess, Fredrick Hagemeister, MD, Jorge Romaguera, MD, Felipe Samaniego, MD, Fernando Cabanillas, MD, Alma Rodriguez, MD, Anas Younes, MD, Michael Wang, MD, Peter McLaughlin, MD
Journal: Blood
Blood (2005) 106 (11): 933.
https://doi.org/10.1182/blood.V106.11.933.933
Published: 2005
Journal Articles

Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma

Clinical Trials & Observations
Apostolia M. Tsimberidou, Peter McLaughlin, Anas Younes, Maria A. Rodriguez, Fredrick B. Hagemeister, Andreas Sarris, Jorge Romaguera, Mark Hess, Terry L. Smith, Ying Yang, Ana Ayala, Alejandro Preti, Ming-Sheng Lee, Fernando Cabanillas
Journal: Blood
Blood (2002) 100 (13): 4351–4357.
https://doi.org/10.1182/blood-2001-12-0269
Published: 2002